Evidence map›Paper›PMID 15673721›Full record

ReviewAntimicrobial agents and chemotherapy2005

Aminoglycoside resistance in Pseudomonas aeruginosa.

Keith Poole

Open access · greenAbstract readReview
In one paragraph

Review in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 176 papers.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 457 citations in OpenAlex.

  1. Article
  2. Article
  3. Antibiotic resistance mechanisms and global resistance patterns of Pseudomonas aeruginosa in microbial keratitis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Review
  5. Article
  6. Discovery of Novel Molecular Scaffolds to OvercomeInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Characterisation of a NovelPathogens (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Differences in antimicrobial resistance between exoU and exoS isolates of Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  13. Disinfectant and antibiotic resistance inMicrobiology spectrum · 2025
    Article
  14. Review
  15. Regulation, structure, and activity of theAntimicrobial agents and chemotherapy · 2025
    Review
  16. Anaerobiosis and Mutations Can Reduce Susceptibility ofPathogens (Basel, Switzerland) · 2025
    Article
  17. Glutamate potentiates susceptibility ofFrontiers in microbiology · 2025
    Article
  18. Genomic and phenotypic characterisation ofFrontiers in microbiology · 2025
    Article
  19. Article
  20. Multidrug ResistantPathogens (Basel, Switzerland) · 2024
    Review

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Keith PooleDepartment of Microbiology & Immunology, Rm. 737 Botterell Hall, Queen's University, Kingston, ON K7L 3N6, Canada. poolek@post.queensu.ca
Queen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialAminoglycosidesAnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsHumansPermeabilityPseudomonas aeruginosaPseudomonas InfectionsAminoglycosidesAnti-Bacterial AgentsBacterial Outer Membrane Proteins

Identifiers

PMID15673721
PMCPMC547279
OpenAlexW2117064229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.